insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.04
arrow_downward
-3.70%(-0.040) 1D
ኖቬም 13, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.12
High
US$1.14
Low
US$1.01
Mkt. cap
46.31 ሚ
Avg. vol.
529.90 ሺ
Volume
328.88 ሺ
52-wk high
US$4.34
52-wk low
US$0.96
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.12
High
US$1.14
Low
US$1.01
Mkt. cap
46.31 ሚ
Avg. vol.
529.90 ሺ
Volume
328.88 ሺ
52-wk high
US$4.34
52-wk low
US$0.96
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
The Motley Fool
·
ከ1 ሰዓት በፊት
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
BigGo Finance
·
ከ2 ሰዓቶች በፊት
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
StoneX
·
ከ2 ቀናት በፊት
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Traders Union
·
ከ4 ሰዓቶች በፊት
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com